Not available
Quote | Esperion Therapeutics Inc. (NASDAQ:ESPR)
Last: | $2.36 |
---|---|
Change Percent: | 0.0% |
Open: | $2.34 |
Close: | $2.36 |
High: | $2.405 |
Low: | $2.32 |
Volume: | 3,880,835 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
News | Esperion Therapeutics Inc. (NASDAQ:ESPR)
2024-06-29 14:31:00 ET The S&P500 ( SP500 ) closed in the red on Friday, after an eventful week that saw companies including Micron Technology ( NASDAQ: MU ) and Nike ( NYSE: NKE ) posting quarterly results. The market also focused on inflation data and the first U.S...
– OMERS Life Sciences to Purchase Esperion’s European Royalty on Bempedoic Acid Products for $304.7 Million with European Royalties Reverting to Esperion Once OMERS Receives 1.7 Times its Investment – – Esperion Retains Rights to Receive all Poten...
Message Board Posts | Esperion Therapeutics Inc. (NASDAQ:ESPR)
Subject | By | Source | When |
---|---|---|---|
What do you make of this? | Johnny_C | investorshub | 06/22/2023 5:05:11 AM |
ESPR - B of A Securities Upgrades Esperion | findit | investorshub | 06/15/2023 12:31:13 PM |
$ESPR what do you make of this data? | keepemcloser | investorshub | 06/14/2023 1:16:55 AM |
What do you make of this? | Johnny_C | investorshub | 06/13/2023 1:16:35 AM |
should we be shorting? | Johnny_C | investorshub | 06/12/2023 8:23:54 AM |
News, Short Squeeze, Breakout and More Instantly...
Esperion Therapeutics Inc. Company Name:
ESPR Stock Symbol:
NASDAQ Market:
Esperion Therapeutics Inc. Website:
– OMERS Life Sciences to Purchase Esperion’s European Royalty on Bempedoic Acid Products for $304.7 Million with European Royalties Reverting to Esperion Once OMERS Receives 1.7 Times its Investment – – Esperion Retains Rights to Receive all Poten...